Page last updated: 2024-08-21

thymoquinone and ADDH

thymoquinone has been researched along with ADDH in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abbas, AN; Abdel-Sattar, SA; Abu-Elfotuh, K; Ahmed, YM; Alshanwani, AR; Atwa, AM; El-Din, MN; Hamdan, AME; Mahran, YF; Reda, E; Zaghlool, SS1

Trials

1 trial(s) available for thymoquinone and ADDH

ArticleYear
The protective effect of thymoquinone or/and thymol against monosodium glutamate-induced attention-deficit/hyperactivity disorder (ADHD)-like behavior in rats: Modulation of Nrf2/HO-1, TLR4/NF-κB/NLRP3/caspase-1 and Wnt/β-Catenin signaling pathways in rat
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 155

    Topics: Animals; Attention Deficit Disorder with Hyperactivity; bcl-2-Associated X Protein; beta Catenin; Brain-Derived Neurotrophic Factor; Calcium; Caspase 1; Dopamine; Glycogen Synthase Kinase 3 beta; Male; NF-E2-Related Factor 2; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Norepinephrine; Rats; RNA, Messenger; Saline Solution; Sodium Glutamate; Thymol; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Wnt Signaling Pathway

2022